Cigna Group
CI297.310USD
-5.450-1.80%
Close 09/15, 16:00（ET）Quotes delayed by 15 min
79.26BMarket Cap
15.80P/E TTM
More Details of Cigna Group Company
The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. The Company’s portfolio of offerings solves diverse challenges across the healthcare system. Evernorth Health Services includes a range of independent and coordinated health solutions and capabilities designed to enable the healthcare system to help people live richer, healthier lives. Health plans, employers, governmental organizations and health care providers partner with Evernorth Health Services to solve their challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. Cigna Healthcare includes the United States healthcare and international health businesses, which provide comprehensive medical and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI) and the Company's run-off operations.
Company Info
Ticker SymbolCI
Company nameCigna Group
IPO dateApr 01, 1982
CEOMr. David M. Cordani, CPA
Number of employees73500
Security typeOrdinary Share
Fiscal year-endApr 01
Address900 Cottage Grove Road
CityBLOOMFIELD
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code06002
Phone18602266000
Websitehttps://www.thecignagroup.com/
Ticker SymbolCI
IPO dateApr 01, 1982
CEOMr. David M. Cordani, CPA
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. David M. Cordani, CPA
Mr. David M. Cordani, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
667.15K
-3.82%
Mr. Brian C. Evanko
Mr. Brian C. Evanko
President, Chief Operating Officer
President, Chief Operating Officer
64.33K
+18.95%
Ms. Donna F. Zarcone, CPA
Ms. Donna F. Zarcone, CPA
Independent Director
Independent Director
26.73K
+2.44%
Mr. Eric C. Wiseman
Mr. Eric C. Wiseman
Lead Independent Director
Lead Independent Director
23.16K
+2.83%
Dr. David J. Brailer, M.D., Ph.D.
Dr. David J. Brailer, M.D., Ph.D.
Executive Vice President, Chief Health Officer and Chief Transformation Officer
Executive Vice President, Chief Health Officer and Chief Transformation Officer
17.52K
-1.63%
Dr. Mark B. Mcclellan, M.D., Ph.D.
Dr. Mark B. Mcclellan, M.D., Ph.D.
Independent Director
Independent Director
6.11K
+11.66%
Maj. Gen. (Retd.) Elder Granger, M.D.
Maj. Gen. (Retd.) Elder Granger, M.D.
Independent Director
Independent Director
6.11K
+11.66%
Ms. Kathleen M. Mazzarella
Ms. Kathleen M. Mazzarella
Independent Director
Independent Director
6.11K
+11.66%
Ms. Kimberly A. Ross
Ms. Kimberly A. Ross
Independent Director
Independent Director
4.51K
+16.47%
Mr. George Kurian
Mr. George Kurian
Independent Director
Independent Director
3.78K
+20.32%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. David M. Cordani, CPA
Mr. David M. Cordani, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
667.15K
-3.82%
Mr. Brian C. Evanko
Mr. Brian C. Evanko
President, Chief Operating Officer
President, Chief Operating Officer
64.33K
+18.95%
Ms. Donna F. Zarcone, CPA
Ms. Donna F. Zarcone, CPA
Independent Director
Independent Director
26.73K
+2.44%
Mr. Eric C. Wiseman
Mr. Eric C. Wiseman
Lead Independent Director
Lead Independent Director
23.16K
+2.83%
Dr. David J. Brailer, M.D., Ph.D.
Dr. David J. Brailer, M.D., Ph.D.
Executive Vice President, Chief Health Officer and Chief Transformation Officer
Executive Vice President, Chief Health Officer and Chief Transformation Officer
17.52K
-1.63%
Dr. Mark B. Mcclellan, M.D., Ph.D.
Dr. Mark B. Mcclellan, M.D., Ph.D.
Independent Director
Independent Director
6.11K
+11.66%
Revenue Breakdown
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2018
By BusinessUSD
Name
Revenue
Proportion
Pharmacy revenues
48.63B
0.00%
Network revenues
28.21B
0.00%
Home delivery and specialty revenues
18.94B
0.00%
Other revenues
3.08B
0.00%
Fees and other revenues
1.87B
0.00%
Intercompany eliminations
-1.61B
0.00%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Pharmacy revenues
48.63B
0.00%
Network revenues
28.21B
0.00%
Home delivery and specialty revenues
18.94B
0.00%
Other revenues
3.08B
0.00%
Fees and other revenues
1.87B
0.00%
Intercompany eliminations
-1.61B
0.00%
Shareholding Stats
Updated: Fri, Aug 15
Updated: Fri, Aug 15
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.59%
BlackRock Institutional Trust Company, N.A.
4.65%
State Street Global Advisors (US)
4.59%
MFS Investment Management
4.28%
T. Rowe Price Associates, Inc.
3.71%
Other
73.18%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.59%
BlackRock Institutional Trust Company, N.A.
4.65%
State Street Global Advisors (US)
4.59%
MFS Investment Management
4.28%
T. Rowe Price Associates, Inc.
3.71%
Other
73.18%
Shareholder Types
Shareholders
Proportion
Investment Advisor
50.59%
Investment Advisor/Hedge Fund
29.00%
Research Firm
2.51%
Hedge Fund
2.38%
Pension Fund
2.33%
Bank and Trust
1.78%
Sovereign Wealth Fund
1.38%
Corporation
1.19%
Individual Investor
0.39%
Other
8.45%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
2945
245.93M
92.13%
-10.11M
2025Q1
2995
251.66M
94.16%
-8.16M
2024Q4
2993
255.45M
93.32%
-4.13M
2024Q3
2931
253.73M
90.72%
-10.03M
2024Q2
2910
254.99M
91.23%
-15.89M
2024Q1
2865
261.02M
89.38%
-14.30M
2023Q4
2815
267.28M
91.36%
-8.83M
2023Q3
2725
267.63M
91.08%
-13.20M
2023Q2
2737
270.13M
91.28%
-8.82M
2023Q1
2710
268.83M
90.70%
-14.56M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
26.02M
9.74%
+45.08K
+0.17%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
13.26M
4.97%
-120.53K
-0.90%
Mar 31, 2025
State Street Global Advisors (US)
12.47M
4.67%
-249.53K
-1.96%
Mar 31, 2025
MFS Investment Management
11.31M
4.23%
+82.46K
+0.73%
Mar 31, 2025
T. Rowe Price Associates, Inc.
11.65M
4.36%
+1.09M
+10.30%
Mar 31, 2025
Dodge & Cox
8.89M
3.33%
+117.13K
+1.34%
Mar 31, 2025
Fidelity Management & Research Company LLC
10.52M
3.94%
+544.14K
+5.45%
Mar 31, 2025
Sanders Capital, LLC
7.99M
2.99%
-65.52K
-0.81%
Mar 31, 2025
Geode Capital Management, L.L.C.
6.04M
2.26%
+79.50K
+1.33%
Mar 31, 2025
GQG Partners, LLC
4.89M
1.83%
+865.09K
+21.51%
Mar 31, 2025
View more
Related ETFs
Updated: Wed, Aug 6
Updated: Wed, Aug 6
Name
Proportion
iShares U.S. Healthcare Providers ETF
3.99%
VictoryShares Free Cash Flow ETF
3.94%
Invesco Dynamic Buyback Achievers ETF
3.83%
Monarch Dividend Plus Index ETF
2.86%
Fidelity Blue Chip Value ETF
2.75%
VictoryShares US Multi-Factor Minimum Vol ETF
2.59%
Brandes US Value ETF
2.27%
Davis Select US Equity ETF
2.21%
First Trust Health Care Alphadex Fund
2.19%
Bushido Capital US Equity ETF
2.16%
View more
iShares U.S. Healthcare Providers ETF
Proportion3.99%
VictoryShares Free Cash Flow ETF
Proportion3.94%
Invesco Dynamic Buyback Achievers ETF
Proportion3.83%
Monarch Dividend Plus Index ETF
Proportion2.86%
Fidelity Blue Chip Value ETF
Proportion2.75%
VictoryShares US Multi-Factor Minimum Vol ETF
Proportion2.59%
Brandes US Value ETF
Proportion2.27%
Davis Select US Equity ETF
Proportion2.21%
First Trust Health Care Alphadex Fund
Proportion2.19%
Bushido Capital US Equity ETF
Proportion2.16%
Dividend
A total of
5.74B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Jan 30, 2025
CI.NB Interim Cash Dividend of gross USD 1.51 paid on Mar 20, 2025 going ex on Mar 05, 2025 with reinvestment option
Mar 05, 2025
Mar 20, 2025
Mar 05, 2025
Oct 23, 2024
CI.NB Final Cash Dividend of gross USD 1.4 paid on Dec 19, 2024 going ex on Dec 04, 2024
Dec 04, 2024
Dec 19, 2024
Dec 04, 2024
Jul 24, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Sep 19, 2024 going ex on Sep 04, 2024 with reinvestment option
Sep 04, 2024
Sep 19, 2024
Sep 04, 2024
Apr 24, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Jun 20, 2024 going ex on Jun 04, 2024 with reinvestment option
Jun 04, 2024
Jun 20, 2024
Jun 04, 2024
Feb 02, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Mar 21, 2024 going ex on Mar 05, 2024 with reinvestment option
Mar 06, 2024
Mar 21, 2024
Mar 05, 2024
Oct 25, 2023
CI.NB Final Cash Dividend of gross USD 1.23 paid on Dec 21, 2023 going ex on Dec 05, 2023
Dec 06, 2023
Dec 21, 2023
Dec 05, 2023
Jul 26, 2023
CI.NB Interim Cash Dividend of gross USD 1.23 paid on Sep 21, 2023 going ex on Sep 05, 2023 with reinvestment option
Sep 06, 2023
Sep 21, 2023
Sep 05, 2023
Apr 26, 2023
CI.NB Interim Cash Dividend of gross USD 1.23 paid on Jun 22, 2023 going ex on Jun 06, 2023 with reinvestment option
Jun 07, 2023
Jun 22, 2023
Jun 06, 2023
Feb 03, 2023
CI.NB Interim Cash Dividend of gross USD 1.23 paid on Mar 23, 2023 going ex on Mar 07, 2023 with reinvestment option
Mar 08, 2023
Mar 23, 2023
Mar 07, 2023
Oct 26, 2022
CI.NB Final Cash Dividend of gross USD 1.12 paid on Dec 21, 2022 going ex on Dec 05, 2022
Dec 06, 2022
Dec 21, 2022
Dec 05, 2022
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
